[Renal function in experimental potassium depletion. I. Effects of lysine-8-vasopressin in hypotonic polyuria]. 1989

G C Agnoli, and R Borgatti, and M Cacciari, and C Garutti, and E Ikonomu, and P Lenzi, and M Marinelli

Renal function has been studied by the clearance (cl.) method during hypotonic polyuria--four 15-min cl. periods--and successive antidiuresis--two 60-min cl. periods (A1, A2)--induced by lysine-8-vasopressin (LVP), 5 mU in bolus followed by infusion at a rate of 0.04 mU/min. The endogenous creatinine cl. (Cc) and the osmotic cls. (Cosm, CH2O) were determined by the usual methods as well as the absolute and fractional urinary excretions of water, sodium, chloride and potassium. The urinary concentrations of PGE2, 6-keto-PGF1 alpha and TxB2 were determined by the RIA method. This study protocol has been applied to 28 healthy women either in normal potassium balance (N, n = 14) or after potassium depletion (KD) induced by low potassium dietary intake (less than or equal to 10 meq/d) plus natriuretic treatment according to two different time patterns: two KD groups were obtained with potassium cumulative deficit of 160 +/- 43 (D2, n = 8) and 198 +/- 22 meq (D3, n = 6). The early % effects of LVP, i.e. (A1-P)% of P (mean polyuria), were significantly different only in D3 as compared to N. Precisely, the LVP-effect to reduce Cc was blunted; moreover a LVP-effect to reduce renal sodium and chloride fractional excretions and a tendentiously enhanced LVP-effect to reduce water fractional excretion were observed. These tubular effects are likely related to the inhibited renal synthesis of prostanoids in the D3 group.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008236 Lypressin The porcine antidiuretic hormone (VASOPRESSINS). It is a cyclic nonapeptide that differs from ARG-VASOPRESSIN by one amino acid, containing a LYSINE at residue 8 instead of an ARGININE. Lys-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Lysine Vasopressin,Vasopressin, Lysine,8-Lysine Vasopressin,Diapid,Lys-Vasopressin,Lysyl Vasopressin,Postacton,8 Lysine Vasopressin,Lys Vasopressin,Vasopressin, 8-Lysine,Vasopressin, Lysyl
D011141 Polyuria Urination of a large volume of urine with an increase in urinary frequency, commonly seen in diabetes (DIABETES MELLITUS; DIABETES INSIPIDUS). Polyurias
D011191 Potassium Deficiency A condition due to decreased dietary intake of potassium, as in starvation or failure to administer in intravenous solutions, or to gastrointestinal loss in diarrhea, chronic laxative abuse, vomiting, gastric suction, or bowel diversion. Severe potassium deficiency may produce muscular weakness and lead to paralysis and respiratory failure. Muscular malfunction may result in hypoventilation, paralytic ileus, hypotension, muscle twitches, tetany, and rhabomyolysis. Nephropathy from potassium deficit impairs the concentrating mechanism, producing POLYURIA and decreased maximal urinary concentrating ability with secondary POLYDIPSIA. (Merck Manual, 16th ed) Deficiencies, Potassium,Deficiency, Potassium,Potassium Deficiencies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013929 Thromboxane B2 A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin). B2, Thromboxane
D015121 6-Ketoprostaglandin F1 alpha The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue. 6-Keto-PGF1 alpha,6-Oxo-PGF1 alpha,6-Oxoprostaglandin F1 alpha,6 Ketoprostaglandin F1 alpha,6 Keto PGF1 alpha,6 Oxo PGF1 alpha,6 Oxoprostaglandin F1 alpha,F1 alpha, 6-Ketoprostaglandin,F1 alpha, 6-Oxoprostaglandin,alpha, 6-Keto-PGF1,alpha, 6-Ketoprostaglandin F1,alpha, 6-Oxo-PGF1,alpha, 6-Oxoprostaglandin F1
D015232 Dinoprostone The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. PGE2,PGE2alpha,Prostaglandin E2,Prostaglandin E2alpha,PGE2 alpha,Prepidil Gel,Prostaglandin E2 alpha,Prostenon,E2 alpha, Prostaglandin,E2, Prostaglandin,E2alpha, Prostaglandin,Gel, Prepidil,alpha, PGE2,alpha, Prostaglandin E2

Related Publications

G C Agnoli, and R Borgatti, and M Cacciari, and C Garutti, and E Ikonomu, and P Lenzi, and M Marinelli
July 1961, Schweizerische medizinische Wochenschrift,
G C Agnoli, and R Borgatti, and M Cacciari, and C Garutti, and E Ikonomu, and P Lenzi, and M Marinelli
January 1983, Scandinavian journal of plastic and reconstructive surgery,
G C Agnoli, and R Borgatti, and M Cacciari, and C Garutti, and E Ikonomu, and P Lenzi, and M Marinelli
January 1984, Scandinavian journal of plastic and reconstructive surgery,
G C Agnoli, and R Borgatti, and M Cacciari, and C Garutti, and E Ikonomu, and P Lenzi, and M Marinelli
May 1964, Endocrinology,
G C Agnoli, and R Borgatti, and M Cacciari, and C Garutti, and E Ikonomu, and P Lenzi, and M Marinelli
August 1984, Bollettino della Societa italiana di biologia sperimentale,
G C Agnoli, and R Borgatti, and M Cacciari, and C Garutti, and E Ikonomu, and P Lenzi, and M Marinelli
January 1963, Deutsche medizinische Wochenschrift (1946),
G C Agnoli, and R Borgatti, and M Cacciari, and C Garutti, and E Ikonomu, and P Lenzi, and M Marinelli
February 1986, The Journal of endocrinology,
G C Agnoli, and R Borgatti, and M Cacciari, and C Garutti, and E Ikonomu, and P Lenzi, and M Marinelli
August 1980, Contraception,
G C Agnoli, and R Borgatti, and M Cacciari, and C Garutti, and E Ikonomu, and P Lenzi, and M Marinelli
January 1985, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
G C Agnoli, and R Borgatti, and M Cacciari, and C Garutti, and E Ikonomu, and P Lenzi, and M Marinelli
February 1967, The Journal of laboratory and clinical medicine,
Copied contents to your clipboard!